Le Lézard
Classified in: Health
Subject: SVY

Global Cerebral Palsy Treatment Market 2019-2023: Increasing Dependency of Patients on Medications for Cerebral Palsy


DUBLIN, Nov. 21, 2018 /PRNewswire/ --

The "Global Cerebral Palsy Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Cerebral Palsy Treatment Market to grow at a CAGR of 5.42% during the period 2019-2023.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of cerebral palsy across the globe.

According to the report, one driver influencing this market is the driven by the rising incidences of cerebral palsy. The lack of proper pre-natal care may increase the chances of children developing cerebral palsy and it is becoming quite widespread in both developed and developing countries which will contribute to the growth of the market.

One trend affecting this market is the increasing dependency of patients on medications for cerebral palsy. Cerebral palsy is a neurological condition associated with severe medical conditions and most patients develop a dependence on medications for cerebral palsy.

Further, the report states that one challenge affecting this market is the complex and multifactorial etiology. Defining one particular therapy to target the challenges of cerebral palsy is difficult as the disease has a complex etiology which may impede the growth of the market.

Key questions answered in this report

Market Dynamics

Key vendors

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE

PART 10: GEOGRAPHIC LANDSCAPE

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

PART 15: VENDOR ANALYSIS

PART 16: APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/sqgwjv/global_cerebral?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....



News published on and distributed by: